Lapis PRO
Natural health product licensed in Canada
- Licence holder
- DISTRIBUTION SOSOMA INC.
- NPN or DIN-HM
- 80087995
- Status
- Active licence
- Licence date
- 24 August 2018
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | minimum: 1 Capsule ; maximum: 2 Capsule | 1 day |
Uses authorised in Canada
Source of antioxidants for the maintenance of good health. Traditionally used in Herbal Medicine to help relieve sore throat and/or other mouth and throat infections.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If you are pregnant or breastfeeding, do not use this product.
- Précautions et mises en garde
If symptoms persist or worsen, or if new symptoms develop, discontinue use and consult a health care practitioner. If you are taking prescription medications, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you are allergic to bee products, poplar tree products, or balsam of Peru.
- Effets indésirables connus
Hypersensitivity, such as allergy, has been known to occur; in which case, discontinue use immediately.
Source
Official Health Canada record, licence 80087995
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.